Publication | Closed Access

Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged

Multimodality Treatment OptionsHepatologyMedicineBiliary CancerPathologyMultimodalityLiver CancerOncologyMultimodality TherapyPoor SurvivalHepatocellular CarcinomaRadiology